[Glitazones in type 2 diabetes--documented risks, uncertain benefits]

Lakartidningen. 2007 Oct;104(43):3198-200.
[Article in Swedish]
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Evidence-Based Medicine
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Pioglitazone
  • Risk Factors
  • Rosiglitazone
  • Thiazolidinediones / adverse effects
  • Thiazolidinediones / chemistry
  • Thiazolidinediones / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone
  • Pioglitazone